NCT03663543 - Intravenous Estrogen in Kidney Transplant Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 26, 2016

Primary Completion Date

January 31, 2026

Study Completion Date

May 1, 2026

Conditions

Ischemia Reperfusion Injury

Interventions

DRUG

Conjugated Estrogen

Dosing of conjugated estrogen will be given pre kidney transplant procedure and twice after reperfusion of the transplanted kidney.

DRUG

Normal saline

Dosing of normal saline will be given pre kidney transplant procedure and twice after reperfusion of the transplanted kidney.

Trial Locations (1)

University of Pennsylvania, Philadelphia

All Listed Sponsors

lead

University of Pennsylvania

OTHER